Second National Conference on Human Retroviruses. Good news, bad news, and no news. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Second National Conference on Human Retroviruses. Good news, bad news, and no news. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Clin Care. 1995 Apr;7(4):30, 33. Unique Identifier : AIDSLINE AIDS/95700181
Del Rio, C; Consejo Nacional de Prevencion y Control del SIDA, Mexico City,; Mexico.

Abstract: The second annual National Conference on Human Retroviruses and Related Infections was held in Washington, D.C., January 29-February 2, 1995. Lectures addressed such topics as viral dynamics, United States AIDS epidemiology, immunopathogenesis, antiretroviral therapy, and HIV vaccines. Symposia were held on the interactivity of sexually transmitted diseases (STDs) and AIDS, the causes leading to long-term nonprogressors, and factors causing individuals to be exposed but uninfected. Oral presentations reviewed the following: 1) a study on the efficacy of oral ganciclovir for prevention of CMV disease in CMV-seropositive, HIV-infected individuals with CD4 counts of 50 or less; 2) data supporting rifabutin prophylaxis against MAC infection once the CD4 count is below 100; 3) the safety of the screened blood supply in the United States; 4) ACTG 063, a study examining the use of AZT with and without acyclovir; 5) perinatal transmission; and 6) four independent studies examining the efficacy of 3TC (lamivudine) as part of a combination of antiretroviral drugs in HIV-infected patients who were both AZT-naive and AZT-experienced.
Keywords: Antiviral Agents/THERAPEUTIC USE AIDS-Related Opportunistic Infections/COMPLICATIONS Blood Transfusion Disease Transmission, Vertical Epidemiology Human Immunity, Cellular *Retroviridae *Retroviridae Infections Sexually Transmitted Diseases/COMPLICATIONS Virus Replication NEWSLETTER ARTICLE

KWDantiviralagents/therapeuticuseaids-relatedopportunisticinfections/complicationsbloodtransfusiondiseasetransmission,verticalepidemiologyhumanimmunity,cellularKWDretroviridaeKWDretroviridaeinfectionssexuallytransmitteddiseases/complicationsvirusreplicationnewsletterarticle
951130
M95B0925

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .